Literature DB >> 11044272

The global programme to eliminate lymphatic filariasis.

E A Ottesen.   

Abstract

Ten years ago, no one foresaw that in the year 2000 there would be a Global Programme to Eliminate Lymphatic Filariasis (GPELF) that is already 2 years old, active in 18 of the 80 endemic countries, and operating under a wholly new paradigm in public health - a paradigm affirming that public/private sector partnerships are essential in sharing both responsibilities and responses to global health problems. What has driven the LF Elimination Programme to this point? Where it is now headed? What will be required to sustain its momentum? What will its impact be? These are the issues addressed below.

Entities:  

Mesh:

Year:  2000        PMID: 11044272     DOI: 10.1046/j.1365-3156.2000.00620.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  108 in total

1.  Update on Lymphatic Filarial Infections.

Authors:  Paul B. Keiser; Thomas B. Nutman
Journal:  Curr Infect Dis Rep       Date:  2002-02       Impact factor: 3.725

2.  Possible relationship among socio-economic determinants, knowledge and practices on lymphatic filariasis and implication for disease elimination in India.

Authors:  Perumal Vanamail; Subbaiah Gunasekaran
Journal:  Int J Public Health       Date:  2010-06-15       Impact factor: 3.380

3.  Effects of albendazole on Litomosoides chagasfilhoi (Nematoda: Filarioidea) females in vivo.

Authors:  Melissa Q Cárdenas; Aleksandra Oliveira-Menezes; Reinalda M Lanfredi
Journal:  Parasitol Res       Date:  2010-06-29       Impact factor: 2.289

4.  Use of a simple DNA extraction method for high-throughput detection of filarial parasite Wuchereria bancrofti in the vector mosquitoes.

Authors:  V Vasuki; S Subramanian; S L Hoti; P Jambulingam
Journal:  Parasitol Res       Date:  2012-07-10       Impact factor: 2.289

Review 5.  Diurnally subperiodic filariasis in India-prospects of elimination: precept to action?

Authors:  A N Shriram; K Krishnamoorthy; B P Saha; Avijit Roy; V Kumaraswami; W A Shah; P Jambulingam; P Vijayachari
Journal:  Parasitol Res       Date:  2011-02-01       Impact factor: 2.289

Review 6.  Are coinfections of malaria and filariasis of any epidemiological significance?

Authors:  Ephantus J Muturi; Benjamin G Jacob; Chang-Hyun Kim; Charles M Mbogo; Robert J Novak
Journal:  Parasitol Res       Date:  2007-11-20       Impact factor: 2.289

7.  Mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea: changes in microfilaremia, filarial antigen, and Bm14 antibody after cessation.

Authors:  Daniel J Tisch; Moses J Bockarie; Zachary Dimber; Benson Kiniboro; Nandao Tarongka; Fred E Hazlett; Will Kastens; Michael P Alpers; James W Kazura
Journal:  Am J Trop Med Hyg       Date:  2008-02       Impact factor: 2.345

8.  A longitudinal analysis of the effect of mass drug administration on acute inflammatory episodes and disease progression in lymphedema patients in Leogane, Haiti.

Authors:  Brittany A Eddy; Anna J Blackstock; John M Williamson; David G Addiss; Thomas G Streit; Valery M Beau de Rochars; Leanne M Fox
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

9.  A laboratory-based surveillance system for Wuchereria bancrofti in Togo: a practical model for resource-poor settings.

Authors:  Els Mathieu; Ameyo Dorkenoo; Felix K J Otogbe; Philip J Budge; Yao K Sodahlon
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

10.  Effect of Diethylcarbamazine (DEC) on prostaglandin levels in Wuchereria bancrofti infected microfilaraemics.

Authors:  T Sankari; S L Hoti; L K Das; V Govindaraj; P K Das
Journal:  Parasitol Res       Date:  2013-03-24       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.